LeMaitre Vascular, Inc. Ranked In 2005 Deloitte Technology Fast 500

BURLINGTON, Mass., Oct. 20 /PRNewswire/ -- LeMaitre Vascular today announced that it ranked Number 435 on the 2005 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America. Rankings are based on percentage revenue growth over five years, from 2000- 2004. LeMaitre Vascular grew 290 percent during this period.

LeMaitre Vascular’s CEO, George W. LeMaitre, attributes the company’s rapid growth over the past five years to the company’s single-minded focus on one customer: the vascular surgeon. He said, “We are honored to be recognized by Deloitte for our achievements. Our strategy of identifying and penetrating profitable vascular niches with differentiated products and a premier sales force is leading us into ever-larger markets and positioning us for future success.”

“Making the Deloitte Technology Fast 500 is commendable in today’s highly competitive technology industry,” said Tony Kern, deputy national managing principal of Deloitte’s Technology, Media & Telecommunications industry practice. “We congratulate LeMaitre Vascular on being one of the 500 fastest growing technology companies in North America.”

In addition to ranking on Deloitte’s Technology Fast 500, LeMaitre Vascular has ranked on the New England Technology Fast 50, a ranking of the 50 fastest growing technology firms in New England, for the past 2 years.

Fast 500 Selection and Qualifications

The Fast 500 list is compiled from Deloitte’s 15 regional North American Fast 50 lists, nominations submitted directly to the Fast 500, and public company database research. To qualify for the Fast 500, entrants must have had 2000 operating revenues of at least $50,000 USD or $75,000 CD for the United States and Canada, respectively, and 2004 operating revenues of at least $1 million USD or CD. Entrants must be headquartered in North America and must be a “technology company,” defined as a company that owns proprietary technology that contributes to a significant portion of the company’s operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies’ technology in a unique way does not qualify.

About LeMaitre

Founded in 1983, LeMaitre Vascular is a privately held vascular device company headquartered in Burlington, Massachusetts. LeMaitre Vascular designs, manufactures and markets vascular surgery devices and has manufacturing facilities in Burlington (MA), Phoenix (AZ) & Brymbo (UK), international headquarters in Sulzbach (Germany) and Asian offices in Tokyo (Japan). LeMaitre Vascular bills itself as a “Surgeons’ Cooperative” with 100 vascular surgeon investors.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other’s acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names “Deloitte”, “Deloitte & Touche”, “Deloitte Touche Tohmatsu” or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.

Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP.

LeMaitre Vascular

CONTACT: Kim Cieslak of LeMaitre Vascular, Inc., +1-781-221-2266, or+1-781-221-2223, kcieslak@lemaitre.com

MORE ON THIS TOPIC